RenovoRx, Inc.
RNXT- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001574094
No open-market purchases or sales by RenovoRx, Inc. insiders were filed in the last 90 days; 28 institutions reported holding it in 13F filings for Q2 2026, worth $9.00M in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding RenovoRx, Inc. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Q4 2025 | Change |
|---|---|---|---|
| Holders | 31 | 33 | +2 |
| Shares | 7.13M | 6.58M | −553.8K (−7.8%) |
| Value | $9.04M | $6.83M | −$2.21M (−24.5%) |
New holders (8)
Institutions that held RenovoRx, Inc. at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Wealthspire Advisors, LLC | 252,525 | $212.1K | 0.00% |
| Susquehanna International Group, LLP | 90,009 | $75.6K | 0.00% |
| CAPROCK Group, Inc. | 63,940 | $53.7K | 0.00% |
| Cypress Point Wealth Management, LLC | 20,000 | $16.8K | 0.00% |
| Two Sigma Securities, LLC | 19,649 | $16.5K | 0.00% |
| Ground Swell Capital, LLC | 13,611 | $11.4K | 0.02% |
| Cetera Investment Advisers | 11,000 | $9.24K | 0.00% |
| Morgan Stanley | 1,121 | $942 | 0.00% |
Sold out (6)
Institutions that held RenovoRx, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| AWM Investment Company, Inc. | 863,790 | $1.10M |
| Corsair Capital Management, L.P. | 93,473 | $118.7K |
| Charles Schwab Investment Management Inc | 49,232 | $62.5K |
| Brighton Jones LLC | 10,656 | $13.5K |
| Barclays PLC | 118 | $150 |
| SBI Securities Co., Ltd. | 2 | $3 |